BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 118 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $202,000 | -10.6% | 17,112 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $226,000 | -8.5% | 17,112 | +45.0% | 0.00% | – |
| Q1 2022 | $247,000 | +2.9% | 11,802 | 0.0% | 0.00% | – |
| Q4 2021 | $240,000 | -33.0% | 11,802 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $358,000 | +4.4% | 11,802 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $343,000 | +42.3% | 11,802 | +111.1% | 0.00% | – |
| Q1 2021 | $241,000 | +9.5% | 5,591 | +17.2% | 0.00% | – |
| Q4 2020 | $220,000 | -10.2% | 4,771 | -15.6% | 0.00% | -100.0% |
| Q3 2020 | $245,000 | +10.4% | 5,651 | +35.2% | 0.00% | 0.0% |
| Q2 2020 | $222,000 | – | 4,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |